Predictors of pathological upgrading in low-risk gleason grade group 1 prostate cancer on prostate biopsy: the role of clinical and tumor-specific factors

Current Problems in Cancer · Published 2026-07-10 · DOI 10.1016/j.currproblcancer.2026.101317

Authors (4)

Shirin Razdan, Ali Fathollahi, Alexandre Armache, Sanjay Razdan

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Razdan, S., Fathollahi, A., Armache, A., et al. (2026). Predictors of pathological upgrading in low-risk gleason grade group 1 prostate cancer on prostate biopsy: the role of clinical and tumor-specific factors. Current Problems in Cancer. https://doi.org/10.1016/j.currproblcancer.2026.101317

Related articles

• Efficacy of atezolizumab, bevacizumab, carboplatin, and paclitaxel for epidermal growth factor receptor mutation-positive advanced non-small cell lung cancer after tyrosine kinase inhibitor failure · Current Problems in Cancer · 2025 · Same journal
• Immune checkpoint expression and therapeutic implications in IDH1-mutant and wild-type glioblastomas · Current Problems in Cancer · 2025 · Same journal
• Outcomes for females versus males treated with eribulin mesylate for advanced urothelial carcinoma · Current Problems in Cancer · 2026 · Same journal
• A phase 2 prospective trial of re-irradiation of locally recurrent or second primary head and neck tumors using stereotactic body radiation therapy · Current Problems in Cancer · 2025 · Same journal
• Unraveling the microbiome’s role in breast cancer progression and treatment response · Current Problems in Cancer · 2025 · Same journal
• Multicenter retrospective study on the clinical profiles of patients with extensive-stage small-cell lung cancer who met the eligibility criteria for clinical trials · Current Problems in Cancer · 2026 · Same journal
• Patterns of care for older multiple myeloma patients in the U.S.: An analysis of the national cancer database · Current Problems in Cancer · 2026 · Same journal
• Immune-metabolic plasticity in AML: Prognostic roles of aCTLs (activated Cytotoxic T Cells) and Kynurenine · Current Problems in Cancer · 2026 · Same journal
• The current state of proton radiotherapy · Current Problems in Cancer · 2024 · Same journal
• Angiogenesis biomarkers in prostate cancer: Unlocking new avenues for prognosis and diagnosis · Current Problems in Cancer · 2025 · Same journal